Amyotrophic lateral sclerosis: an update on treatments from clinical trials

被引:2
作者
Wynford-Thomas, Ray [1 ,2 ]
Robertson, Neil P. P. [2 ]
机构
[1] Univ Hosp Wales, Dept Neurol, Heath Pk, Cardiff CF14 4XN, Wales
[2] Cardiff Univ, Univ Hosp Wales, Dept Neurol, Div Psychol Med & Clin Neurosci, Heath Pk, Cardiff CF14 4XN, Wales
关键词
D O I
10.1007/s00415-022-11553-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1187 / 1189
页数:3
相关论文
共 3 条
[1]   Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial [J].
Cudkowicz, Merit ;
Genge, Angela ;
Maragakis, Nicholas ;
Petri, Susanne ;
van den Berg, Leonard ;
Aho, Valtteri V. ;
Sarapohja, Toni ;
Kuoppamaki, Mikko ;
Garratt, Chris ;
Al-Chalabi, Ammar .
LANCET NEUROLOGY, 2021, 20 (10) :821-831
[2]   Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS [J].
Miller, Timothy M. ;
Cudkowicz, Merit E. ;
Genge, Angela ;
Shaw, Pamela J. ;
Sobue, Gen ;
Bucelli, Robert C. ;
Chio, Adriano ;
Van Damme, Philip ;
Ludolph, Albert C. ;
Glass, Jonathan D. ;
Andrews, Jinsy A. ;
Babu, Suma ;
Benatar, Michael ;
McDermott, Christopher J. ;
Cochrane, Thos ;
Chary, Sowmya ;
Chew, Sheena ;
Zhu, Han ;
Wu, Fan ;
Nestorov, Ivan ;
Graham, Danielle ;
Sun, Peng ;
McNeill, Manjit ;
Fanning, Laura ;
Ferguson, Toby A. ;
Fradette, Stephanie .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12) :1099-1110
[3]   Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis [J].
Thonhoff, Jason R. ;
Berry, James D. ;
Macklin, Eric A. ;
Beers, David R. ;
Mendoza, Patricia A. ;
Zhao, Weihua ;
Thome, Aaron D. ;
Triolo, Fabio ;
Moon, James J. ;
Paganoni, Sabrina ;
Cudkowicz, Merit ;
Appel, Stanley H. .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (06)